Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$14.32 Mil
% of Total Estimate Gain
3.56%

FARALLON CAPITAL MANAGEMENT LLC's Bristol-Myers Squibb Co Holding Summary

As of 2025-03-31, FARALLON CAPITAL MANAGEMENT LLC held - shares of Bristol-Myers Squibb Co(BMY), totaling N/A. This investment constitutes 0% of their stock portfolio, and FARALLON CAPITAL MANAGEMENT LLC now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.

The initial trade took place in 2020Q2. And since then FARALLON CAPITAL MANAGEMENT LLC has made 3 purchases of BMY, at an average price of $58.00, for a total of 6.94 Mil shares. In addition, there have been 3 sales at an average price of $60.06 for 6.94 Mil shares. Based on historical transaction data and BMY's current price of $47.66, FARALLON CAPITAL MANAGEMENT LLC's estimated gain on his BMY holdings is $14.32 Mil, reflecting a 3.56% gain to date.

FARALLON CAPITAL MANAGEMENT LLC BMY ($47.66) Holding Chart

FARALLON CAPITAL MANAGEMENT LLC BMY ($47.66) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1